BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 35453634)

  • 1. Novel Translational Read-through-Inducing Drugs as a Therapeutic Option for Shwachman-Diamond Syndrome.
    Bezzerri V; Lentini L; Api M; Busilacchi EM; Cavalieri V; Pomilio A; Diomede F; Pegoraro A; Cesaro S; Poloni A; Pace A; Trubiani O; Lippi G; Pibiri I; Cipolli M
    Biomedicines; 2022 Apr; 10(4):. PubMed ID: 35453634
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ataluren improves myelopoiesis and neutrophil chemotaxis by restoring ribosome biogenesis and reducing p53 levels in Shwachman-Diamond syndrome cells.
    Cipolli M; Boni C; Penzo M; Villa I; Bolamperti S; Baldisseri E; Frattini A; Porta G; Api M; Selicato N; Roccia P; Pollutri D; Marinelli Busilacchi E; Poloni A; Caporelli N; D'Amico G; Pegoraro A; Cesaro S; Oyarbide U; Vella A; Lippi G; Corey SJ; Valli R; Polini A; Bezzerri V
    Br J Haematol; 2024 Jan; 204(1):292-305. PubMed ID: 37876306
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ataluren-driven restoration of Shwachman-Bodian-Diamond syndrome protein function in Shwachman-Diamond syndrome bone marrow cells.
    Bezzerri V; Bardelli D; Morini J; Vella A; Cesaro S; Sorio C; Biondi A; Danesino C; Farruggia P; Assael BM; D'amico G; Cipolli M
    Am J Hematol; 2018 Aug; 93(4):527-536. PubMed ID: 29285795
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nonsense Suppression Therapy: New Hypothesis for the Treatment of Inherited Bone Marrow Failure Syndromes.
    Bezzerri V; Api M; Allegri M; Fabrizzi B; Corey SJ; Cipolli M
    Int J Mol Sci; 2020 Jun; 21(13):. PubMed ID: 32630050
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SBDS expression and localization at the mitotic spindle in human myeloid progenitors.
    Orelio C; Verkuijlen P; Geissler J; van den Berg TK; Kuijpers TW
    PLoS One; 2009 Sep; 4(9):e7084. PubMed ID: 19759903
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of an asymptomatic Shwachman-Bodian-Diamond syndrome mutation in a patient with acute myeloid leukemia.
    Shibata S; Inano S; Watanabe M; Fujiwara K; Ueno H; Nannya Y; Kanda J; Kawasaki N; Okamoto Y; Takiuchi Y; Fukunaga A; Tabata S; Ogawa S; Takaori-Kondo A; Kitano T
    Int J Hematol; 2022 Mar; 115(3):428-434. PubMed ID: 34704233
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutation analysis of SBDS in pediatric acute myeloblastic leukemia.
    Majeed F; Jadko S; Freedman MH; Dror Y
    Pediatr Blood Cancer; 2005 Dec; 45(7):920-4. PubMed ID: 16007594
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutations in signal recognition particle SRP54 cause syndromic neutropenia with Shwachman-Diamond-like features.
    Carapito R; Konantz M; Paillard C; Miao Z; Pichot A; Leduc MS; Yang Y; Bergstrom KL; Mahoney DH; Shardy DL; Alsaleh G; Naegely L; Kolmer A; Paul N; Hanauer A; Rolli V; Müller JS; Alghisi E; Sauteur L; Macquin C; Morlon A; Sancho CS; Amati-Bonneau P; Procaccio V; Mosca-Boidron AL; Marle N; Osmani N; Lefebvre O; Goetz JG; Unal S; Akarsu NA; Radosavljevic M; Chenard MP; Rialland F; Grain A; Béné MC; Eveillard M; Vincent M; Guy J; Faivre L; Thauvin-Robinet C; Thevenon J; Myers K; Fleming MD; Shimamura A; Bottollier-Lemallaz E; Westhof E; Lengerke C; Isidor B; Bahram S
    J Clin Invest; 2017 Nov; 127(11):4090-4103. PubMed ID: 28972538
    [TBL] [Abstract][Full Text] [Related]  

  • 9.
    Mourad S; Bilodeau M; Roussy M; Laramée L; Boulianne L; Rouette A; Jouan L; Gendron P; Duval M; Teira P; Hébert J; Bittencourt H; Pastore Y; Landry JR; Cellot S
    Front Oncol; 2019; 9():772. PubMed ID: 31475115
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SBDS protein expression patterns in the bone marrow.
    Wong TE; Calicchio ML; Fleming MD; Shimamura A; Harris MH
    Pediatr Blood Cancer; 2010 Sep; 55(3):546-9. PubMed ID: 20658628
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The isochromosome i(7)(q10) carrying c.258+2t>c mutation of the SBDS gene does not promote development of myeloid malignancies in patients with Shwachman syndrome.
    Minelli A; Maserati E; Nicolis E; Zecca M; Sainati L; Longoni D; Lo Curto F; Menna G; Poli F; De Paoli E; Cipolli M; Locatelli F; Pasquali F; Danesino C
    Leukemia; 2009 Apr; 23(4):708-11. PubMed ID: 19148133
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inducible Sbds deletion impairs bone marrow niche capacity to engraft donor bone marrow after transplantation.
    Zha J; Kunselman LK; Xie HM; Ennis B; Shah YB; Qin X; Fan JM; Babushok DV; Olson TS
    Blood Adv; 2022 Jan; 6(1):108-120. PubMed ID: 34625796
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Comparative Molecular Dynamics Study of Selected Point Mutations in the Shwachman-Bodian-Diamond Syndrome Protein SBDS.
    Spinetti E; Delre P; Saviano M; Siliqi D; Lattanzi G; Mangiatordi GF
    Int J Mol Sci; 2022 Jul; 23(14):. PubMed ID: 35887285
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Counteracting the Common Shwachman-Diamond Syndrome-Causing
    Peretto L; Tonetto E; Maestri I; Bezzerri V; Valli R; Cipolli M; Pinotti M; Balestra D
    Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36835434
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ataluren for the Treatment of Usher Syndrome 2A Caused by Nonsense Mutations.
    Samanta A; Stingl K; Kohl S; Ries J; Linnert J; Nagel-Wolfrum K
    Int J Mol Sci; 2019 Dec; 20(24):. PubMed ID: 31842393
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TGFβ signaling underlies hematopoietic dysfunction and bone marrow failure in Shwachman-Diamond Syndrome.
    Joyce CE; Saadatpour A; Ruiz-Gutierrez M; Bolukbasi OV; Jiang L; Thomas DD; Young S; Hofmann I; Sieff CA; Myers KC; Whangbo J; Libermann TA; Nusbaum C; Yuan GC; Shimamura A; Novina CD
    J Clin Invest; 2019 Jun; 129(9):3821-3826. PubMed ID: 31211692
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural and mutational analysis of the SBDS protein family. Insight into the leukemia-associated Shwachman-Diamond Syndrome.
    Shammas C; Menne TF; Hilcenko C; Michell SR; Goyenechea B; Boocock GR; Durie PR; Rommens JM; Warren AJ
    J Biol Chem; 2005 May; 280(19):19221-9. PubMed ID: 15701631
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New insights into the Shwachman-Diamond Syndrome-related haematological disorder: hyper-activation of mTOR and STAT3 in leukocytes.
    Bezzerri V; Vella A; Calcaterra E; Finotti A; Gasparello J; Gambari R; Assael BM; Cipolli M; Sorio C
    Sci Rep; 2016 Sep; 6():33165. PubMed ID: 27658964
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical features and outcomes of patients with Shwachman-Diamond syndrome and myelodysplastic syndrome or acute myeloid leukaemia: a multicentre, retrospective, cohort study.
    Myers KC; Furutani E; Weller E; Siegele B; Galvin A; Arsenault V; Alter BP; Boulad F; Bueso-Ramos C; Burroughs L; Castillo P; Connelly J; Davies SM; DiNardo CD; Hanif I; Ho RH; Karras N; Manalang M; McReynolds LJ; Nakano TA; Nalepa G; Norkin M; Oberley MJ; Orgel E; Pastore YD; Rosenthal J; Walkovich K; Larson J; Malsch M; Elghetany MT; Fleming MD; Shimamura A
    Lancet Haematol; 2020 Mar; 7(3):e238-e246. PubMed ID: 31879230
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutations of the SBDS gene are present in most patients with Shwachman-Diamond syndrome.
    Woloszynek JR; Rothbaum RJ; Rawls AS; Minx PJ; Wilson RK; Mason PJ; Bessler M; Link DC
    Blood; 2004 Dec; 104(12):3588-90. PubMed ID: 15284109
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.